|
BBNX Beta Bionics Inc 1674632 |
| Balance Sheet |
|
Current Assets
|
$231,034,000.00 |
|
Assets
|
$292,387,000.00 |
|
Current Liabilities
|
$26,017,000.00 |
|
Liabilities
|
$36,021,000.00 |
|
Equity
|
$256,366,000.00 |
|
Shares Out
|
44981606.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-38,454,000.00 |
|
Investing Cash Flow
|
$48,772,000.00 |
| Market Analysis |
Market Cap
|
$876,241,684.88 |
|
Price
|
$21.89 |
|
BVPS
|
5.70 |
|
PB
|
3.42 |
|
EPS
|
-0.53 |
|
PS
|
6.84 |
|
FCF
|
$-40,870,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:29 |
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-17 |
-0.30 |
| Apr |
May |
Jun |
|
|
2026-04-21 |
-0.49 |
|
|
| Jul |
Aug |
Sep |
|
|
2025-07-29 |
-0.39 |
|
|
| Oct |
Nov |
Dec |
|
|
2025-10-28 |
-0.33 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BBNX documents filed with the SEC.
BBNX Filings
Clear